Efficacy of Tazobactam/Piperacillin on urosepsis (multicenter-study)

Efficacy of Tazobactam/Piperacillin on urosepsis (multicenter-study) - Efficacy of TAZ/PIPC on urosepsis (multicenter-study)

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000028607

Enrollment

114

Registered

2017-08-10

Start date

2017-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urosepsis

Interventions

Efficacy of Tazoctam/piperacillin(TAZ/PIPC) on urosepsis treatments

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: the patients with Urosepsis with consent of inclusion in this study

Exclusion criteria

Exclusion criteria: 19 years older or younger or those patients without consent of inclusion in this study

Design outcomes

Primary

Measure	Time frame
To evaluate the change of subjective- and objective- symptoms and blood examination on 1, 2, 3 and 4 weeks of treatments.	—

Countries

Japan

Contacts

Public ContactKatsumi Shigemura

Kobe University Hospital Urology, Health Science

katsumi@med.kobe-u.ac.jp078-382-6155

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026